This inventor holds 1 USPTO granted patent. Top assignees: Univerzita Palackeho V Olomouci, Ustav Anorganicke Chemie Akademie Ved Ceske Republiky, V.v.i., Ustav Molekularni Genetiky Akademie Ved Ceske Republiky, V.v.i.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 36 
1 out of 1 
1 out of 1 Years Active: 2016
Title: **Innovative Contributions of Inventor Josef Holub**
Introduction
Josef Holub is a distinguished inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of cancer research. With one patented invention to his name, Holub is recognized for his innovative approach to developing carbonic anhydrase inhibitors.
Latest Patents
Holub's sole patent focuses on "Carbonic anhydrase inhibitors and method of their production" which involves derivatives of boron cluster compounds. This patent outlines the production of pharmaceutically acceptable salts and solvates, which specifically inhibit the enzyme carbonic anhydrase IX, a protein that is often overexpressed in cancer tissues. The methods of synthesis and application for these novel derivatives highlight their potential use in pharmaceuticals, not only for the diagnostic purpose but also for the therapeutic treatment of cancer diseases.
Career Highlights
Throughout his career, Josef Holub has been associated with prominent research institutions, including the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, as well as the Institute of Molecular Genetics of the Czech Academy of Sciences. His tenure at these institutions has allowed him to explore various facets of organic chemistry and biochemistry, contributing to his innovative patent achievements.
Collaborations
Holub collaborated with esteemed colleagues such as Jiri Brynda and Petr Cigler. Their collective expertise has contributed to advancing research in biochemistry and molecular genetics, further enhancing the impact of Holub's inventions in understanding and treating cancer.
Conclusion
Josef Holub's innovative work in carbonic anhydrase inhibitors stands as a testament to the potential for scientific discovery to address critical health challenges. His contributions not only pave the way for new therapeutic options in cancer treatment but also showcase the collaborative spirit of research within scholarly institutions. As cancer research continues to evolve, the implications of Holub's inventions may play a crucial role in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile